Abbott Laboratories (ABT) Q3 2018 Earnings Report

0 Followers

MX:ABT Q3 2018 EPS Results

Actual EPS: MXN 14.13
Consensus EPS: ―
Beat/Miss: ―
One Year Ago EPS: MXN 12.43

MX:ABT Q3 2018 Revenue Results

Actual Revenue: MXN 144.22B
Expected Revenue: ―
Beat/Miss: ―
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q3 2018
Date: 10/17/2018
Time: Before Open
Conference Call: Wednesday, October 17, 2018

MX:ABT Upcoming Earnings

Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ABT Earnings History

MX:ABT earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Jan 27, 2027	2026 (Q4)	30.86-	28.26	―	―
Oct 21, 2026	2026 (Q3)	26.7526.75	24.49	9.23% (+2.26)
Jul 16, 2026	2026 (Q2)	24.0624.68	23.74	3.97% (+0.94)
Apr 16, 2026	2026 (Q1)	21.5721.66	20.53	5.50% (+1.13)
Jan 22, 2026	2025 (Q4)	28.1828.26	25.24	11.94% (+3.01)
Oct 15, 2025	2025 (Q3)	24.5524.49	22.79	7.44% (+1.70)
Jul 17, 2025	2025 (Q2)	23.6623.74	21.47	10.53% (+2.26)
Apr 16, 2025	2025 (Q1)	20.1920.53	18.46	11.22% (+2.07)
Jan 22, 2025	2024 (Q4)	25.3025.24	22.42	12.61% (+2.83)
Oct 16, 2024	2024 (Q3)	22.6422.79	21.47	6.14% (+1.32)
Jul 18, 2024	2024 (Q2)	20.8221.47	20.34	5.56% (+1.13)
Apr 17, 2024	2024 (Q1)	17.9918.46	19.4	-4.85% (-0.94)
Jan 24, 2024	2023 (Q4)	22.4222.42	19.4	15.53% (+3.01)
Oct 18, 2023	2023 (Q3)	20.7421.47	21.66	-0.87% (-0.19)
Jul 20, 2023	2023 (Q2)	19.7820.34	26.94	-24.48% (-6.59)
Apr 19, 2023	2023 (Q1)	18.6519.40	32.59	-40.46% (-13.19)
Jan 25, 2023	2022 (Q4)	17.4419.40	24.87	-21.97% (-5.46)
Oct 19, 2022	2022 (Q3)	17.7621.66	26.37	-17.86% (-4.71)
Jul 20, 2022	2022 (Q2)	21.2326.94	22.04	22.22% (+4.90)
Apr 20, 2022	2022 (Q1)	27.6032.59	24.87	31.06% (+7.72)
Jan 26, 2022	2021 (Q4)	22.7224.87	27.31	-8.97% (-2.45)
Oct 20, 2021	2021 (Q3)	17.8026.37	18.46	42.86% (+7.91)
Jul 22, 2021	2021 (Q2)	19.1822.04	10.74	105.26% (+11.30)
Apr 20, 2021	2021 (Q1)	―24.87	12.24	103.08% (+12.62)
Jan 27, 2021	2020 (Q4)	―27.31	17.9	52.63% (+9.42)
Oct 21, 2020	2020 (Q3)	―18.46	15.82	16.67% (+2.64)
Jul 16, 2020	2020 (Q2)	―10.74	15.45	-30.49% (-4.71)
Apr 16, 2020	2020 (Q1)	―12.24	11.87	3.17% (+0.38)
Jan 22, 2020	2019 (Q4)	―17.90	15.26	17.28% (+2.64)
Oct 16, 2019	2019 (Q3)	―15.82	14.13	12.00% (+1.70)
Jul 17, 2019	2019 (Q2)	―15.45	13.75	12.33% (+1.70)
Apr 17, 2019	2019 (Q1)	―11.87	11.11	6.78% (+0.75)
Jan 23, 2019	2018 (Q4)	―15.26	13.94	9.46% (+1.32)
Oct 17, 2018	2018 (Q3)	―14.13	12.43	13.64% (+1.70)
Jul 18, 2018	2018 (Q2)	―13.75	11.68	17.74% (+2.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Abbott Laboratories earnings date